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Purpose: To investigate the preventive effect of dietary zerumbone against UVB-induced cataractogenesis.
Methods: A total of 50 six-week-old female ICR mice were split into five groups (each contained 10 mice) and exposed
to UVB (0.72 J/cm2/daily) at noon for 7 days, except for the blank control group. The mice with UVB exposure were fed
with zerumbone as a dietary supplement at 0, 1, 10, and 100 mg/kg of bodyweight, respectively, starting from one day
before UVB exposure. On day 7, at 4 h after UVB exposure, all mice were subjected to cataract examination and lens
opacity scoring, in correlation with levels of MDA (malondialdehyde), GSH (glutathione), GR (GSH reductase), GPx
(glutathione peroxidase), and SOD (superoxide dismutase) in the lens.
Results: Dietary zerumbone at 100 mg/kg after UVB exposure was effective in decreasing lens opacity scores (p<0.001)
and to reduce MDA (p<0.001), while GSH and GR levels were significantly increased (both p<0.001) in the lens. SOD
was also increased with dietary zerumbone at 100 mg/kg (p=0.115), whereas GPx (p=0.171) levels were lower as compared
with those without zerumbone after UVB exposure.
Conclusions: These results suggest that zerumbone may protect against UVB-induced cataractogensis through reducing
lipid peroxides and enhancing the endogenous antioxidant GSH level and GR activity.
Cataract formation is one of the leading causes of human
blindness worldwide. Most cataracts are not congenital and
ultraviolet radiation from sunlight plays a paramount role
during cataractogensis, as epidemiological studies indicate
high exposure to sunlight in early life poses an increased risk
of cataract formation later in life [1]. Ultraviolet radiation with
wavelengths between 290 and 320 nm (designated as UVB)
is particularly relevant to cataract development [2,3], since the
energy of UVB is substantially absorbed within the lens. The
relevance  between  lens  UVB  absorption  and  cataract
formation  was  substantially  indicated  in  several  mouse
models  established  to  elucidate  genetic  and  biochemical
factors during UVB-induced cataractogenesis [4-6].
During cataractogenesis, opacification occurs in the lens
cells  through  degenerative  mechanisms,  including
proteolysis,  oxidation,  and  stress-induced  protein
aggregation.  The  detrimental  effects  induced  by  UVB
irradiation  act  mainly  through  the  formation  of  reactive
oxygen  species  (ROS)  or  free  radicals,  such  as  hydrogen
peroxide  (H2O2),  the  devastatingly-toxic  hydroxyl  radical
(OH‧), and superoxide (O2·-) [7,8]. Cataract formation, like
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many other degenerative ocular diseases, occurs when the rate
of ROS production outpaces the rate of removal [8,9]. For
example, the polyunsaturated lipids within plasma membrane
of the lens fiber cells are liable to be targeted when ROS or
free radicals are accumulated, leading to the initiation of early
cataractogenesis. Particularly, malondialdehyde (MDA), an
end  product  of  lipid  peroxidation,  is  increased  in  animal
[10-13] and human cataract [14-16]. Previous studies also
showed that MDA could deteriorate lens cell opacification
through modification and cross-linking soluble lens proteins,
such as α-crystallin or oxidative crystallins [17,18].
Without proper protection, the transparent ocular lens is
doomed to be attacked by oxidative damage because the lens
fiber  cells  are  not  renewed  and  have  to  last  a  lifetime.
However,  the  lens  is  equipped  with  antioxidant  defense
mechanisms [19,20]. Under normal physiologic conditions,
ROS are constitutively produced and balanced by various
defense  mechanisms,  including  antioxidant  enzymes,  free
radical scavengers, and metal-chelating agents, that have been
developed through evolution to protect cells from damage.
The  antioxidant  enzymes  include  glutathione  peroxidase
(GPx) and superoxide dismutase (SOD). SOD catalyzes the
dismutation  of  superoxide  (O2-)  to  hydrogen  peroxide
(H2O2), while GPx converts H2O2 to H2O and O2 [21,22]. The
free radical scavengers include ascorbate, α-tocopherol and
glutathione  (GSH).  Particularly,  GSH  contains  triple
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723functions, acting not only as a free radical scavenger, but also
as a regulator to regenerate other scavengers and as a substrate
in the GPx reaction [21,22].
Zerumbone  (ZER;  2,6,9,9-tetramethyl-
cycloundeca-2,6,10-trien-1-one) is a sesquiterpenoid (Figure
1A)  found  in  large  amounts  in  the  rhizome  of  Zingiber
zerumbet, a plant traditionally used in the Southeast Asian
countries  as  an  anti-inflammatory  agent  and  also  as  a
condiment [23-26]. Recent in vitro experiments have shown
that zerumbone may be potentially used as an antitumor drug
[24,27-30]. It was shown to exert anti-inflammatory effects
through  inhibition  of  nuclear  factor-kappa  B  (NF-κB)
activation and repression of the de novo synthesis of iNOS
and cyclooxygenase-2 [26,27,30]. Besides, zerumbone has
been widely reported to act as a free radical scavenger with
antioxidant properties but without evident side effects to the
normal cells [26,30-34].
Most of previous studies on zerumbone were focused on
its in vitro chemopreventive and chemotherapeutic effects.
The potential in vivo beneficial effects of zerumbone through
its  anti-oxidative  characteristic  have  not  been  extensively
investigated. This study investigated the effects of dietary
zerumbone  on  UVB-induced  cataractogenesis  in  a  mouse
model,  since  there  had  been  no  report  on  zerumbone
application in this aspect. Our results showed that dietary
zerumbone  acts  to  inhibit  opacification  and  reduce  MDA
accumulation  in  the  eye  lens  following  UVB  exposure.
Besides, we showed that dietary zerumbone can increase the
production of GSH (an ROS scavenger) and GR (an anti-
oxidant enzyme), following UVB exposure. Without prior
publication on the same subject, these results represent the
first assessment of zerumbone as a candidate agent against
UVB-induced cataractogenesis.
METHODS
Animals: A total of 50 six-week-old female ICR mice were
purchased from National Laboratory Animal Center, Taipei,
Taiwan. The mice weighted about 25 g on arrival and were
fed ad libitum and kept under standard conditions with a 12-
h light/dark cycle. The mice were acclimatized and habituated
to the laboratory for at least one week before experiments. All
mice were examined with a slit lamp (Model 99 BQ; Haag-
Streit,  Bern,  Switzerland)  before  experiments.  Only  mice
without anomalies of the anterior segment of the eye (cornea,
anterior  chamber,  iris,  or  lens)  were  included  in  the
experiments.
Ultraviolet B irradiation and study groups: The 50 mice were
randomly split into five groups (each contained 10 mice),
including (1) UVB (exposure to UVB without treatment), (2)
UVB/ZER (1 mg/kg; exposure to daily UVB with zerumbone
treatment at 1 mg/kg bodyweight), (3) UVB/ZER (10 mg/kg;
exposure to daily UVB with zerumbone treatment at 10 mg/
kg bodyweight), (4) UVB/ZER (100 mg/kg; exposure to daily
UVB with zerumbone treatment at 100 mg/kg bodyweight),
and  (5)  Blank  control  (no  daily  UVB  exposure   and
no     zerumbone     treatment).     In     the     four     UVB
irradiation   groups,   the   mice   were   anaesthetized
with intraperitoneal injection of sodium pentobarbital (45 mg/
kg bodyweight). Both of the mice eyes were exposed to daily
UVB light from VL-6 UV lamp (set at 0.72 J/cm2; with peak
wavelength at 312 nm) in the CN-6 darkroom chamber (Vilber
Lourmat, Eberhardzell, Germany). Prior to UVB exposure,
0.1% tropicamide was applied to both eyes for pupil dilation.
The distance between UV lamp and the mouse cornea was
fixed  at  16  cm.  After  the  UVB  exposure,  the  mice  were
allowed for recovery and then transferred to their original
cage. The UVB irradiation was performed for a consecutive
7-day period (Day 1 to Day7 in Figure 1B). The UVB light
was  measured  using  a  UV  detector  (VLX-3W;  Vilber
Lourmat) from the same company. The irradiation intensity
on the cornea surface was 8mW/cm2 and wavelength ranged
between 310 to 315 nm. All experiments were reviewed and
approved by the Animal Care and Use Committee in Chung
Shan Medical University and were performed in agreement
Figure 1. Zerumbone chemical structure and experimental design for dietary zerumbone supplementation after UVB irradiation to the mouse
lens. A: The structure of zerumbone. B: Both of the mice eyes were exposed to UVB light (0.72J/cm2/daily) at noon for a consecutive 7-day
period until sacrifice for analysis at 4:00 PM on Day 7.
Molecular Vision 2011; 17:723-730 <http://www.molvis.org/molvis/v17/a82> © 2011 Molecular Vision
724with  the  Association  for  Research  in  Vision  and
Ophthalmology (ARVO) Resolution on the Use of Animals
in Research.
Dietary zerumbone supplementation: Dietary zerumbone was
supplemented in mouse chow at doses of 0, 1, 10, and 100 mg
per kg of bodyweight, starting from Day 0 (one day before
UVB exposure) and terminated on the day of analysis (Day 7
in Figure 1B). Zerumbone was purchased from Kingherbs,
Inc., Hainan, China.
Lens  opacity  scoring:  The  extent  of  cataractogenesis  was
assessed and lens opacity was determined on day 7. Before
the examination, the mice were anaesthetized with sodium
pentobarbital at 30–40 mg/kg and their pupils were dilated by
instillation  of  a  1%  tropicamide  and  10%  phenylephrine
mixture. After being anaesthetized with pupils dilated, all
mice  were  assessed  for  lens  opacity  in  left  eyes.  Briefly,
biomicroscopy was performed in all of the five groups. The
lens opacity scores were determined by using a 0 to 4 points
scoring system based on the following criteria: 0=Normal,
transparent  lenses;  1=Lenses  showing  slightly  hazy,
translucent; 2=Lenses displaying moderate hazy, translucent;
3=Lenses displaying dense haze or point opacities; 4=Lenses
displaying definite cataract [35]. The scorings were performed
by 2 observers without prior knowledge of the UVB exposure
and study groups. Cataract formation was photographed with
a  Nikon  SMZ-645  dissection  microscope  (Nikon,  Tokyo,
Japan) equipped with top ring light and a digital camera.
Determination of MDA levels: MDA levels in the lens were
determined according to the procedures published by Ohkawa
et al. [36], by using a fluorometric method in which 1,1,3,3
tetramethoxypropane was used as standard and the results
were given as nmol/ml. Lenses were extracted from mice and
homogenized  in  ice-cold  homogenate  buffer  containing
0.25% sodium dodecyl sulfate (SDS), 0.65% phosphotungstic
acid, 0.05 N HCL and 0.15% thiobarbituric acid (TBA). After
thorough homogenization, the lens homogenate was heated
and maintained at 99 °C for 45 min. After cooling, the sample
was mixed with 130 μl of butanol and shaken vigorously.
After centrifugation at 450× g for 10 min, the organic layer
was separated and its absorbance was recorded at 555 nm. The
protein levels of lens homogenate were measured with a Bio-
Rad Protein Assay kit (Life Science Research, Hercules, CA)
using  BSA  as  standard,  and  MDA  level  of  the  lens  was
expressed as nmol/mg protein. Only one eye from each mouse
was randomly chosen for each MDA determination to ensure
independent observation.
Quantification of GSH levels and GSH reductase activity: The
lenses were extracted from mice and homogenized in ice-cold
HEPES  buffer  (pH  7.2).  The  lens  homogenate  was  then
subject  to  centrifugation  at  9,000×  g  for  15  min.  After
centrifugation, the supernatants were collected and assayed
for  GSH  level  and  GSH  reductase  activity  immediately.
Tissue protein levels were measured with a Bio-Rad Protein
Assay kit (Life Science Research) using BSA as standard.
GSH concentration (nmole/mg) was measured according to
the  enzymatic  recycling  method  of  Anderson  [37].  The
amount of total GSH was determined based on a standard
curve obtained with known amounts of GSH standards. GR
activity  (U/mg)  was  measured  through  the  reduction  of
oxidized glutathione (GSSG) into GSH, which was catalyzed
by GR with NADPH as the cofactor. The decrease in the
optical density at 340 nm was recorded at 25 °C for 3 min and
then the units of enzymatic activity were calculated using an
extinction coefficient of NADPH. One unit was equivalent to
the oxidation of 1 mmol of NADPH per min. Only one eye
from  each  mouse  was  randomly  chosen  for  each
quantification  of  GSH  levels  or  GR  activity,  to  ensure
independent observation.
Determination of GPx and SOD activity: The lenses were
extracted from mice and homogenized in ice-cold 20-mM
HEPES buffer (pH 7.2) and centrifugated at 9,000× g for 15
min. After centrifugation, the supernatants were collected and
assayed  for  GPx  and  SOD  activity  immediately.  Tissue
protein levels were measured with a Bio-Rad Protein Assay
kit  (Life  Science  Research)  using  BSA  as  standard.  GPx
activity was determined by the method of Paglia et al. [38], in
which  GPx  was  measured  as  a  catalyst  for  glutathione
oxidation in the presence of hydrogen peroxide (H2O2) with a
spectrophotometer set at 340 nm and read against a blank
reagent. GPx activity was expressed as units/mg protein (U/
mg  protein).  One  unit  represents  the  activity  of  enzyme
capable of converting 1 μmol of reduced glutathione (GSH)
to the oxidized form of glutathione (GSSH) in the presence of
H2O2/min.  Superoxide  dismutase  (SOD)  was  measured
according to the method of Sun et al. [39]. In this method,
xanine-xantine oxidase complex produces superoxide radicals
which react with nitro blue tetrazolium (NBT) to form the
formazan compound. SOD activity was measured at 450 nm
on a spectrophotometer by detecting the inhibition of this
reaction.  The  activity  of  SOD  was  calculated  as  follows:
Percent inhibition (%)=((Ablank – Asample) / Ablank) × 100, in
which Ablank and Asample represent the absorbance values of the
blank  and  the  sample,  respectively.  SOD  activity  was
expressed  as  units/mg  protein  (U/mg  protein)  which
represents the enzyme activity capable of inhibiting 50% of
the NBT reduction rate. Only one eye from each mouse was
randomly  chosen  for  each  quantification  of  GPx  or  SOD
activity, to ensure independent observation.
Statistical analysis: All data were obtained from triple repeats
and are presented as the means±standard error of the means
(SEMs) and were compared among study groups. The lens
opacity scores were compared by Mann–Whitney test. The
levels of MDA, GSH, GR, GPx, and SOD were analyzed by
Mann–Whitney-U test and Kruskal–Wallis test.
RESULTS
Zerumbone  prevents  UVB-induced  cataract  formation  as
reflected by lower lens opacity scoring: At the end of the
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725experiment (at 4:00 PM on day 7), the mice were anesthetized
with their pupils dilated for examination. The lens in UVB
group  showed  apparent  opacification  (Figure  2A  and  its
corresponding negative image), in contrast to the apparent
transparent lens in the blank control group (Figure 2E and
negative image). Dietary zerumbone apparently prevented the
UVB-exposed  lenses  from  cataractogenesis  in  a  dose-
dependent manner (Figure 2B-D; and negative images), with
the most effective dose at 100 mg/kg. The results of lens
opacity  scoring  were  in  agreement  with  the  cataract
examination  (Figure  2F).  Also,  it  appeared  that  dietary
zerumbone started to prevent UVB-induced cataractogenesis
at 10 mg/kg.
Zerumbone reduces MDA and GSH levels in the lens with
UVB irradiation: MDA level was determined to understand
whether zerumbone helps to deplete its accumulation in the
lens.  As  shown  in  Figure  1,  MDA  accumulation  was
significantly increased with UVB exposure, as compared to
that  of  the  blank  control  group  (0.222±0.013  versus
0.064±0.013  nmol/mg  protein;  p=0.001).  With  dietary
zerumbone supplementation, MDA levels were reduced, with
significant  difference  starting  at  10  mg/kg.  (48.20%
reduction), as compared to that of the UVB group without
zerumbone. When dietary zerumbone was supplemented at
100 mg/kg, 76.13% reduction was achieved. In agreement
with the reduction of MDA accumulation, GSH level was
elevated  with  dietary  zerumbone  at  100  mg/kg  when
compared  to  that  of  the  UVB  group  without  zerumbone
(17.71±0.99 versus 13.05±1.10 nmol/mg protein; p=0.001).
Increase of GR and SOD and decrease of GPx activities with
dietary zerumbone: Comparative to the increase of GSH, GR
activity was also elevated (4.00±0.44 versus 2.02±0.51 U/mg
protein;  p=0.001)  at  100  mg/kg  of  dietary  zerumbone  as
compared to the UVB group without zerumbone. Particularly,
98.02% increase of GR activity was seen. SOD activity was
also  increased  with  100  mg/kg  zerumbone  supplement  as
compared  to  that  of  the  UVB  group  without  zerumbone
(1.32±0.21 versus 1.17±0.15 U/mg protein; p=0.115), but not
as significant as the elevations of GSH level and GR activity.
However, GPx activity was decreased with 100 mg/kg of
zerumbone supplementation, as compared to that of the UVB
group without zerumbone (3.48±0.70 versus 3.99±0.55 U/mg
protein;  p=0.172).  Interestingly,  UVB  exposure  leads  to
increase  of  GPx  activity  in  the  lens  without  zerumbone
supplementation, when compared to that of the blank control
(3.99±0.55 versus 3.51±0.32 U/mg protein; p=0.059).
DISCUSSION
Since UV exposure is inevitable, preventive measures against
the phototoxic effects caused by UVB have been extensively
studied. UV shields should be used for physical protection to
minimize exposure. Chemically, depletion of reactive oxygen
species  (ROS)  and  free  radicals  and  inhibition  of
inflammatory  factors  constitute  two  major  means  to
ameliorate UVB-induced phototoxic status. Thus, ideally, a
candidate  compound  should  be  antioxidant  and  anti-
inflammatory. Zerumbone represents a good candidate as it
contains the dual functions. Thus, this study investigated the
chemical  preventive  effects  of  zerumbone  against  UVB-
induced cataract formation. We found that zerumbone given
at 100 mg/kg as a dietary supplement after UVB exposure was
able to decrease the lens opacity scores (p<0.001) and to
reduce  MDA  levels  (p<0.001),  in  agreement  with  the
significantly increased GSH and GR levels (both p<0.001) in
the  lens.  Besides,  SOD  was  also  increased  with  dietary
zerumbone at 100 mg/kg (p=0.115), but GPx (p=0.171) levels
were lower as compared with those without zerumbone after
UVB  exposure.  Out  results  support  the  potential  use  of
Figure 2. Comparison and quantification of lens opacity among groups of UVB (UVB exposure without dietary zerumbone), UVB/ZER (UVB
exposure with dietary zerumbone at 1, 10, and 100 mg/kg respectively), and blank control (no UVB exposure and no dietary zerumbone).
A-E: Severe cataract formation was seen in the UVB-irradiated lens in (A) and its corresponding negative image, which was reversed with
zerumbone supplementation as shown in (C) and (D). F: Lens opacity scoring showed the inhibitory effect of zerumbone on cataract formation.
Scale bar: 1.25 mm.
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726zerumbone  as  a  preventive  agent  against  UVB-induced
cataract formation.
The  underlying  mechanisms  of  zerumbone  against
cataract formation are likely to be derived from combinatorial
effects.  First,  the  lens,  like  all  tissues,  is  equipped  with
endogenous  antioxidant  defense  mechanisms  to  protect
against the harmful effects of UVB and ROS. However, when
UVB exposure becomes excessive to an extent that surpasses
the  endogenous  defense  capacity,  exogenous  antioxidant
supplements will be determinative in cataract formation in the
lens.  Zerumbone  has  been  reported  to  have  antioxidant
activity in several in vitro and in vivo cancer models [24,27,
32,40-42].  Therefore,  it  is  reasonable  to  interpret  its
preventive effects against cataractogenesis through its ability
to  eliminate  free  radicals  and  scavenge  ROS  in  the  lens.
Second, zerumbone has been found to be able to induce de
novo  expression  of  genes  encoding  detoxifying/defensive
proteins like phase II enzymes [32,33]. These detoxifying/
defensive proteins have been known to prevent against many
degenerative diseases. They are likely to act also to prevent
lens degeneration and thus lens opacification was ameliorated.
Third, many lines of evidence support MDA involvement in
cataractogenesis. Clinically, it has been reported that products
of lipid oxidation, including MDA, increase with cataract
formation  in  the  lens  [14-16].  In  animal  studies,  when
oxidized phospholipids containing MDA were injected into
the vitreous body of rabbits, posterior subcapsular cataract
was induced within 24 h [43]. Therefore, reduction of MDA
in the lens is most likely to inhibit cataractogenesis. Some
researchers  may  doubt  MDA  involvement  in
cataractogenesis, as MDA arises only from the oxidation of
polyunsaturated hydrocarbon lipids, which compose less than
3%  of  lens  membrane  lipids  [44].  However,  since  UVB
irradiation  had  been  reported  to  enhance  the  membrane
permeability of lens epithelial cells [3,45]. It is likely that, in
our model, the UVB-induced MDA production in the cornea,
aqueous humor, vitreous, and retina might easily diffuse to the
lens, resulting in the lens opacity observed in this study. The
same mechanism may also explain the risk of cataract as a
consequence of retinal degeneration or retinal surgery [43,
46]. Zerumbone may act to block the diffusion of MDA from
the  posterior  ocular  tissues  and  thus  decelerate  the
accumulation of MDA in the lens. Alternatively, zerumbone
may accelerate the depletion of MDA in the lens. These two
possible mechanisms, however, remain to be elucidated by
future experiments. Fourthly, cross-linking of α-crystallin by
MDA has been reported previously [17,18]. Upon storage,
MDA  forms  more  reactive  molecules  that  can  cross-link
proteins [17]. Therefore, MDA is not only cytotoxic to the lens
cells. It could aggravate the abnormal cross-linking of soluble
lens crystallins, resulting in worse lens opacification [17,18].
As such, reduction of MDA in the lens is likely to inhibit cross-
linking of crystallins and therefore inhibit cataractogenesis.
Fifthly,  zerumbone  may  induce  directly  or  indirectly  the
synthesis  of  some  free  radical  scavengers  or  anti-oxidant
enzymes in lens cells. Among them, GSH and GR appear to
be crucial, as the indigenous levels were strongly decreased
after  planned  UVB  irradiation  as  compared  to  the  blank
control (both p** [a-e]=0.001; as  shown in  Table 1) and the
decrease  of  GSH  level  and  GR  activity  was  reversed
significantly by dietary zerumbone (10 and 100 mg/kg of
bodyweight).
Adequate nutrition is considered particularly important
in  preventing  ROS-induced  oxidative  damage  and
maintaining the overall health of the eye [47-49]. Many of the
enzymatic cofactors and chemical constituents necessary for
antioxidant  activity  are  obtained  through  the  diet.  For
example, dietary treatment with melatonin was reported to
reduce UVB-induced cataract formation in the experimental
animal studies [50-53]. Our study has shown, for the first time,
TABLE 1. ANTIOXIDNAT CONCENTRATION (LEVEL) IN LENS.
  MDA (nmol/mg
protein)
GSH (nmol/mg
protein)
GR (U/mg
protein)
SOD (U/mg
protein)
GPx (U/mg
protein)
(a) UVB 0.22±0.01 13.05±1.10 2.02±0.51 1.17±0.15 3.99±0.55
(b) UVB/Zerumbone (1mg/kg) 0.19±0.03 12.95±1.56 2.77±0.67 1.25±0.15 3.76±0.49
(c) UVB/Zerumbone (10mg/kg) 0.12±0.01 15.35±1.03 3.16±0.41 1.27±0.13 3.55±0.48
(d) UVB/Zerumbone (100mg/kg) 0.05±0.01 17.71±0.99 4.00±0.44 1.32±0.21 3.48±0.70
(e) Blank control 0.06±0.01 18.15±1.07 4.03±0.48 1.37±0.15 3.51±0.32
Percent change
(a-b) -12.61 -0.77 37.13 6.84 -5.76
(a-c) -48.20 17.62 56.44 8.55 -11.03
(a-d) -76.13 35.71 98.02 12.82 -12.78
p* (a-b-c-d-e) 0.000 0.000 0.000 0.154 0.303
p** (a-b) 0.248 0.834 0.115 0.172 0.345
p** (a-c) 0.001 0.003 0.001 0.172 0.074
p** (a-d) 0.001 0.001 0.001 0.115 0.172
p** (a-e) 0.001 0.001 0.001 0.016 0.059
           p*; Kruskal Wallis test; p**; Mann Whitney U test.
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after  UVB  irradiation.  Particularly,  previous  studies  had
indicated that zerumbone did not cause any harmful effects in
the liver of normal rats [54]. Notably, we fed the mice with
zerumbone   for  7  days   with    a    maximal    dose    at
100  mg/kg.  Taha  et  al.  [54]  performed  intraperitoneal
zerumbone treatment at 60 mg/kg twice a week for 11 weeks
and found no evidence of abnormality in the liver of normal
rats. Another study by Mihye Kim et al. [29] used dietary
zerumbone  at  500  ppm  for  17  weeks  without  finding
inflammatory  response,  mucosal  ulcer,  or  high  grade
dysplasia  in  the  digestive  system.  It  is  likely  that  the
preventive dose of dietary zerumbone against ultraviolet B-
induced  cataractogenesis  may  not  cause  toxic  effects,
although caution must certainly be taken.
We conclude that zerumbone may be potentially used as
a food supplement to prevent against UVB-induced cataract
formation.
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